These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19477605)

  • 1. Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis.
    Hashiguchi T; Tanaka K; Lee LJ; Sasaki K; Natsugoe S; Kawahara K; Arimura K; Maruyama I
    Med Hypotheses; 2009 Nov; 73(5):760-3. PubMed ID: 19477605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive peptidome analysis of mouse livers by size exclusion chromatography prefractionation and nanoLC-MS/MS identification.
    Hu L; Li X; Jiang X; Zhou H; Jiang X; Kong L; Ye M; Zou H
    J Proteome Res; 2007 Feb; 6(2):801-8. PubMed ID: 17269736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry.
    Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ
    Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
    Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
    Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.
    Liotta LA; Petricoin EF
    J Clin Invest; 2006 Jan; 116(1):26-30. PubMed ID: 16395400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer.
    Zheng X; Baker H; Hancock WS
    J Chromatogr A; 2006 Jul; 1120(1-2):173-84. PubMed ID: 16527286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
    Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
    Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of protein fragments as pattern features in MALDI-MS analyses of serum.
    Zimmerman LJ; Wernke GR; Caprioli RM; Liebler DC
    J Proteome Res; 2005; 4(5):1672-80. PubMed ID: 16212420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional protease profiling for diagnosis of malignant disease.
    Findeisen P; Neumaier M
    Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of peptides in serum by C(8)-functionalized magnetic nanoparticles for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis.
    Yao N; Chen H; Lin H; Deng C; Zhang X
    J Chromatogr A; 2008 Mar; 1185(1):93-101. PubMed ID: 18262195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides.
    Penno MA; Ernst M; Hoffmann P
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2656-62. PubMed ID: 19630030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma.
    Yi J; Kim C; Gelfand CA
    J Proteome Res; 2007 May; 6(5):1768-81. PubMed ID: 17411080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amplified peptidome: the new treasure chest of candidate biomarkers.
    Geho DH; Liotta LA; Petricoin EF; Zhao W; Araujo RP
    Curr Opin Chem Biol; 2006 Feb; 10(1):50-5. PubMed ID: 16418009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.